ArticleJournal of cellular and molecular medicine2022

A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells.

Shanzhi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.